Annual Total Debt
$1.77 M
-$419.00 K-19.16%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual total debt is $1.77 million, with the most recent change of -$419.00 thousand (-19.16%) on December 31, 2023.
- During the last 3 years, ABUS annual total debt has fallen by -$1.22 million (-40.73%).
- ABUS annual total debt is now -85.27% below its all-time high of $12.00 million, reached on December 31, 2016.
Performance
ABUS Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.45 M
-$151.00 K-9.46%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly total debt is $1.45 million, with the most recent change of -$151.00 thousand (-9.46%) on September 30, 2024.
- Over the past year, ABUS quarterly total debt has dropped by -$237.00 thousand (-14.08%).
- ABUS quarterly total debt is now -87.95% below its all-time high of $12.00 million, reached on December 31, 2016.
Performance
ABUS Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
ABUS Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.2% | -14.1% |
| 3 y3 years | -40.7% | -33.9% |
| 5 y5 years | +100.0% | -33.9% |
ABUS Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.4% | at low | -44.7% | at low |
| 5 y | 5-year | -47.4% | at low | -56.9% | at low |
| alltime | all time | -85.3% | -100.0% | -88.0% | -100.0% |
Arbutus Biopharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.45 M(-9.5%) |
| Jun 2024 | - | $1.60 M(-5.1%) |
| Mar 2024 | - | $1.68 M(-4.8%) |
| Dec 2023 | $1.77 M(-19.2%) | $1.77 M(-7.4%) |
| Sep 2023 | - | $1.91 M(-6.6%) |
| Jun 2023 | - | $2.04 M(-3.5%) |
| Mar 2023 | - | $2.12 M(-3.2%) |
| Dec 2022 | $2.19 M(-16.3%) | $2.19 M(-5.5%) |
| Sep 2022 | - | $2.31 M(-6.1%) |
| Jun 2022 | - | $2.46 M(-2.9%) |
| Mar 2022 | - | $2.54 M(-2.9%) |
| Dec 2021 | $2.61 M(-12.4%) | $2.61 M(-4.6%) |
| Sep 2021 | - | $2.74 M(-3.2%) |
| Jun 2021 | - | $2.83 M(-2.6%) |
| Mar 2021 | - | $2.91 M(-2.5%) |
| Dec 2020 | $2.98 M(-11.2%) | $2.98 M(-4.1%) |
| Sep 2020 | - | $3.11 M(-3.7%) |
| Jun 2020 | - | $3.23 M(-1.9%) |
| Mar 2020 | - | $3.29 M(-1.9%) |
| Dec 2019 | $3.36 M(>+9900.0%) | $3.36 M(-3.3%) |
| Sep 2019 | - | $3.47 M(-4.6%) |
| Jun 2019 | - | $3.64 M(-6.0%) |
| Mar 2019 | - | $3.87 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $12.00 M(0.0%) | $12.00 M(0.0%) |
| Sep 2017 | - | $12.00 M(0.0%) |
| Jun 2017 | - | $12.00 M(0.0%) |
| Mar 2017 | - | $12.00 M(0.0%) |
| Dec 2016 | $12.00 M(>+9900.0%) | $12.00 M(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2008 | - | $9200.00(-70.4%) |
| Jun 2008 | - | $31.10 K(-39.8%) |
| Mar 2008 | - | $51.70 K(-32.3%) |
| Dec 2007 | $76.40 K(-48.4%) | $76.40 K(-34.1%) |
| Sep 2007 | - | $115.90 K(-1.4%) |
| Jun 2007 | - | $117.50 K |
| Dec 2006 | $148.10 K(+9.6%) | - |
| Dec 2005 | $135.10 K(-92.4%) | - |
| Dec 2004 | $1.78 M(+45.2%) | - |
| Dec 2003 | $1.22 M(>+9900.0%) | - |
| Dec 2002 | $0.00(-100.0%) | - |
| Dec 2001 | $355.50 K(+176.7%) | - |
| Dec 2000 | $128.50 K(+31.5%) | - |
| Dec 1999 | $97.70 K(>+9900.0%) | - |
| Dec 1998 | $0.00 | - |
FAQ
- What is Arbutus Biopharma annual total debt?
- What is the all time high annual total debt for Arbutus Biopharma?
- What is Arbutus Biopharma annual total debt year-on-year change?
- What is Arbutus Biopharma quarterly total debt?
- What is the all time high quarterly total debt for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly total debt year-on-year change?
What is Arbutus Biopharma annual total debt?
The current annual total debt of ABUS is $1.77 M
What is the all time high annual total debt for Arbutus Biopharma?
Arbutus Biopharma all-time high annual total debt is $12.00 M
What is Arbutus Biopharma annual total debt year-on-year change?
Over the past year, ABUS annual total debt has changed by -$419.00 K (-19.16%)
What is Arbutus Biopharma quarterly total debt?
The current quarterly total debt of ABUS is $1.45 M
What is the all time high quarterly total debt for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly total debt is $12.00 M
What is Arbutus Biopharma quarterly total debt year-on-year change?
Over the past year, ABUS quarterly total debt has changed by -$237.00 K (-14.08%)